5 research outputs found

    Proportion of serotypes and resistance genes in acute otitis media patients 2A. <i>S. pneumoniae.</i>

    No full text
    <p>Serotype coverage of 7- and 13-valent pneumococcal conjugate vaccine in this study were 38.0% (95% CI: 29.3–47.3) and 62.8% (95% CI: 53.6–71.4%), respectively. 2B. <i>H. influenzae.</i> Of 122<i> H. influenzae</i> available for typing, 120 were NTHi and 2 were Hib. Resistance genotyping showed that 9% were gBLPACR-III, 43% were gBLNAR-III, 4% were gBLNAR-I/II, 40% were gBLNAS, and 4% were nontypeable. gPSSP, genetically penicillin susceptible <i>S. pneumoniae</i>; gPISP, genetically penicillin intermediate <i>S. pneumoniae</i>; gPRSP, genetically penicillin resistant <i>S. pneumoniae</i>; gBLNAS, genetically beta-lactamase-negative ampicillin-susceptible isolates; gBLNAR, genetically beta-lactamase-negative ampicillin-resistant isolates; gBLPACR, genetically beta-lactamase-positive ampicillin-resistant isolates; NTHi, nontypeable <i>H. influenzae.</i></p
    corecore